| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.5 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |